FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3104486148> ?p ?o ?g. }

• W3104486148 abstract "A new combination therapy consisting of intraarterial chemotherapy plus radiotherapy was demonstrated to have the potential to improve the response rate and survival time in patients with unresectable biliary tract cancer.We retrospectively investigated the effectiveness and safety of a new combination therapy consisting of intraarterial chemotherapy plus radiation therapy (AI+RT), which may have the potential to improve unresectable biliary tract cancer (BTC).We retrospectively reviewed 52 BTC cases treated with AI+RT and analyzed the anti-tumor effect, survival time and adverse events. The AI+RT regimen consisted of one-shot intraarterial chemotherapy (AI) at the first angiography session, almost 6 months of reservoir AI (5-FU and cisplatin, q/week) and external radiation with a maximum dose of 50.6 Gy.The response rate and disease control rate were high, at 40.4% and 96.2%, respectively, and the median overall and progression-free survival time were 463 and 431 days; thus, long-term survival was achieved. A univariate analysis identified 12 prognostic factors, and a performance status of 2 (hazard ratio [HR]: 4.82, p=0.02), jaundice (HR: 3.22, p<0.01), peritoneal dissemination (HR: 22.5, p<0.01), number of AI (HR: 0.35, p=0.01) and response to AI+RT (HR: 0.23, p<0.01) were extracted as significant prognostic factors in a multivariate analysis. The following: grade ≥3 adverse events occurred: leucopenia (11.5%), neutropenia (1.9%), anemia (15.4%), thrombocytopenia (11.5%), anorexia (3.8%), gastroduodenal ulcer (25.0%), and cholangitis (23.1%). There were no cases of treatment-related death.AI+RT was shown to contribute to a high response rate and prolonged survival in patients with unresectable BTC. A sufficient number of AI and the response to this therapy were thought to be significant prognostic factors in patients receiving AI+RT. Advances in multidisciplinary therapies, such as AI+RT, which was described in the present study, are also considered to be important for the future." @default.
• W3104486148 created "2020-11-23" @default.
• W3104486148 creator A5017819742 @default.
• W3104486148 creator A5019626901 @default.
• W3104486148 creator A5026390892 @default.
• W3104486148 creator A5039193840 @default.
• W3104486148 creator A5044429247 @default.
• W3104486148 creator A5047785115 @default.
• W3104486148 creator A5052556463 @default.
• W3104486148 creator A5052564598 @default.
• W3104486148 creator A5056544156 @default.
• W3104486148 creator A5072977928 @default.
• W3104486148 creator A5073129677 @default.
• W3104486148 creator A5089167641 @default.
• W3104486148 date "2020-11-17" @default.
• W3104486148 modified "2023-09-23" @default.
• W3104486148 title "High Response Rate and Prolonged Survival of Unresectable Biliary Tract Cancer Treated With a New Combination Therapy Consisting of Intraarterial Chemotherapy Plus Radiotherapy" @default.
• W3104486148 cites W1506375624 @default.
• W3104486148 cites W1843348728 @default.
• W3104486148 cites W1963537359 @default.
• W3104486148 cites W1989331158 @default.
• W3104486148 cites W1994746695 @default.
• W3104486148 cites W2000042204 @default.
• W3104486148 cites W2003753299 @default.
• W3104486148 cites W2008020015 @default.
• W3104486148 cites W2036423008 @default.
• W3104486148 cites W2054178056 @default.
• W3104486148 cites W2065756402 @default.
• W3104486148 cites W2083472544 @default.
• W3104486148 cites W2087336559 @default.
• W3104486148 cites W2115261608 @default.
• W3104486148 cites W2141078344 @default.
• W3104486148 cites W2144412903 @default.
• W3104486148 cites W2149422956 @default.
• W3104486148 cites W2252843566 @default.
• W3104486148 cites W2296056502 @default.
• W3104486148 cites W2338147491 @default.
• W3104486148 cites W2413634590 @default.
• W3104486148 cites W2419674744 @default.
• W3104486148 cites W2467035461 @default.
• W3104486148 cites W2803932144 @default.
• W3104486148 cites W2807737802 @default.
• W3104486148 doi "https://doi.org/10.3389/fonc.2020.597813" @default.
• W3104486148 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7707151" @default.
• W3104486148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33312956" @default.
• W3104486148 hasPublicationYear "2020" @default.
• W3104486148 type Work @default.
• W3104486148 sameAs 3104486148 @default.
• W3104486148 citedByCount "4" @default.
• W3104486148 countsByYear W31044861482022 @default.
• W3104486148 countsByYear W31044861482023 @default.
• W3104486148 crossrefType "journal-article" @default.
• W3104486148 hasAuthorship W3104486148A5017819742 @default.
• W3104486148 hasAuthorship W3104486148A5019626901 @default.
• W3104486148 hasAuthorship W3104486148A5026390892 @default.
• W3104486148 hasAuthorship W3104486148A5039193840 @default.
• W3104486148 hasAuthorship W3104486148A5044429247 @default.
• W3104486148 hasAuthorship W3104486148A5047785115 @default.
• W3104486148 hasAuthorship W3104486148A5052556463 @default.
• W3104486148 hasAuthorship W3104486148A5052564598 @default.
• W3104486148 hasAuthorship W3104486148A5056544156 @default.
• W3104486148 hasAuthorship W3104486148A5072977928 @default.
• W3104486148 hasAuthorship W3104486148A5073129677 @default.
• W3104486148 hasAuthorship W3104486148A5089167641 @default.
• W3104486148 hasBestOaLocation W31044861481 @default.
• W3104486148 hasConcept C126322002 @default.
• W3104486148 hasConcept C141071460 @default.
• W3104486148 hasConcept C143998085 @default.
• W3104486148 hasConcept C197934379 @default.
• W3104486148 hasConcept C2776283816 @default.
• W3104486148 hasConcept C2776694085 @default.
• W3104486148 hasConcept C2777063308 @default.
• W3104486148 hasConcept C2781413609 @default.
• W3104486148 hasConcept C509974204 @default.
• W3104486148 hasConcept C71924100 @default.
• W3104486148 hasConcept C90924648 @default.
• W3104486148 hasConceptScore W3104486148C126322002 @default.
• W3104486148 hasConceptScore W3104486148C141071460 @default.
• W3104486148 hasConceptScore W3104486148C143998085 @default.
• W3104486148 hasConceptScore W3104486148C197934379 @default.
• W3104486148 hasConceptScore W3104486148C2776283816 @default.
• W3104486148 hasConceptScore W3104486148C2776694085 @default.
• W3104486148 hasConceptScore W3104486148C2777063308 @default.
• W3104486148 hasConceptScore W3104486148C2781413609 @default.
• W3104486148 hasConceptScore W3104486148C509974204 @default.
• W3104486148 hasConceptScore W3104486148C71924100 @default.
• W3104486148 hasConceptScore W3104486148C90924648 @default.
• W3104486148 hasLocation W31044861481 @default.
• W3104486148 hasLocation W31044861482 @default.
• W3104486148 hasLocation W31044861483 @default.
• W3104486148 hasOpenAccess W3104486148 @default.
• W3104486148 hasPrimaryLocation W31044861481 @default.
• W3104486148 hasRelatedWork W1984282923 @default.
• W3104486148 hasRelatedWork W2020898191 @default.
• W3104486148 hasRelatedWork W2112851763 @default.
• W3104486148 hasRelatedWork W2373226427 @default.
• W3104486148 hasRelatedWork W2387456186 @default.
• W3104486148 hasRelatedWork W2387577256 @default.
• W3104486148 hasRelatedWork W2387690194 @default.
• W3104486148 hasRelatedWork W2388730008 @default.

• next